The immunology of Alzheimer's disease: Prospects towards harnessing disease mechanisms for therapeutic ends

Journal of Neuroimmune Pharmacology

Volumn 2, Issue 2, 2007, Pages 131-133

  Landreth, Gary ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE VACCINE;

ALZHEIMER DISEASE; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; REVIEW;

ALZHEIMER DISEASE; ALZHEIMER VACCINES; ANIMALS; HUMANS;

EID: 34247534953     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-007-9067-1     Document Type: Review

References (16)

1. Akiyama H, Barger S, et al (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21(3):383-421
2. Bamberger M, Marris M, et al (2003) A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J Neurosci 23 (7):2665-2674
3. Bonifati DM, Kishore U (2007) Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 44(5):999-1010
4. Colton CA, Mott RT, et al (2006) Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflamm 3:27
5. Combs C, Johnson D, et al (1999) Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J Neurosci 19(3):928-939
6. Eikelenboom P, Veerhuis R, et al (2006) The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Transm 113(11):1685-1695
7. Koenigsknecht J, Landreth G (2004) Microglial phagocytosis of fibrillar beta-amyloid through a betal integrin-dependent mechanism. J Neurosci 24(44):9838-9846
8. McDonald DR, Brunden KR, et al (1997) Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. 3 Neurosci 17(7):2284-2294
9. Morgan D, Gordon MN, et al (2005) Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J Neuropathol Exp Neurol 64(9):743-753
10. Nimmerjahn A, Kirchhoff F, et al (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308(5726):1314-1318
11. Schenk D, Barbour R, et al (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400(6740): 173-177
12. Simard AR, Rivest S (2006) Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease. Mol Psychiatry 11 (4):327-335
13. Venneti S, Lopresti BJ, et al (2006) The peripheral benzodiazepine receptor (Translocator protein 18 kDa) in microglia: from pathology to imaging. Prog Neurobiol 80(6):308-322
14. Wang YJ, Zhou HD, et al (2006) Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives. Drug Discov Today 11(19-20):931-938
15. Weiner HL, Frenkel D (2006) Immunology and immunotherapy of Alzheimer's disease. Nat Rev Immunol 6(5):404-416
16. Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12(9): 1005-1015